Prevalence of Phelan McDermid Syndrome Estimated To Be ~1:7300 Using a Multisource Model
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Neuren Pharmaceuticals. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Neuren Pharmaceuticals a question about this update.